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T h ec o m m e n t a r yb yp r o f e s s o r sG r i f f i na n dW e s t b u r y
[1] seems to be a response to the widespread media cov-
erage following the recent publication of our article [2].
Most of the media coverage was accurate and carefully
emphasized that, while our new approach to measuring
early brain development might be promising for detect-
ing risk for disorders such as autism, it has not yet pro-
v e nt h a ti tw i l ly i e l dt h a td e s i r e dr e s u l ta n dt h a tm u c h
more research is still required.
A common problem with the publication of novel med-
ical research on a disease that has a high level of public
interest is a tendency to see such work as an imminent
breakthrough and/or as having practical clinical implica-
tions (such as an early screening tool). This is not entirely
negative, as it serves to reinforce the unwritten pact
between society and the medical research community:
medical researchers are charged with finding cures and
relieving suffering. Scientists are required to walk the fine
line between pointing out that basic research does indeed
have a pragmatic goal in sight, while emphasizing that
basic science requires exploration of new ideas, which
takes a relatively long time to come to fruition, requiring
many small steps along the way.
Our paper, at its core, is about measurable neural cor-
relates of brain development. Our central claim con-
cerns development: “... modified multiscale entropy ...
can be used as a biomarker of typical brain development
and distinguish typically developing children from a
group of infants at high risk for autism spectrum disor-
der ...” [2].
Many studies suggest that autism is a connectivity dis-
order [3-6]. Thus, the basic neurophysiological cause for
the behaviors that define autism involves a systematic
wiring pattern that differs in some consistent manner
from those that do not exhibit autistic behaviors.
Furthermore, changes in brain developments are known
in at least some cases to precede observable changes in
behavior (given the limited behavioral repertoire of the
young infant, this should come as no surprise). The bio-
physics of neural networks and results from more general
complex network analysis suggest that the time series of
electrical potentials produced by the brain will contain
information about network structure [7-10]. It is thus
reasonable to conjecture that electroencephalography
(EEG) signals may contain discernible patterns, reflecting
something about the underlying neural networks that
precede behavior. In this context, our paper is a first
attempt to begin to look at certain EEG signal features
that are known to be invariant measures of complex sys-
tem dynamics to see if they are indeed correlated with
behaviors or, in this case, possible endophenotypes.
Figure 4 in our paper shows that there are significant
group differences in multiscale entropy (MSE) between
the high risk and typically developing infants. It is of
particular interest that the trajectories for both groups,
in all regions shown, are similar from 6 to 9 and 18 to
24 months. The largest group differences are in changes
from 9 to 12 months. This suggests that the develop-
mental trajectories from 9 to 12 months may be of
greatest interest for discerning the future outcome of
individual infants in these groups, generally supporting
the individual results shown in Table 3. Unfortunately,
at the time of this study, we did not have enough infants
who had measurements at all five ages to enable trajec-
tories for individuals to be analyzed. Nevertheless, the
data provide a strong suggestion that distinctly different
developmental trajectories are followed from 9 to 12
months in these two groups.
In our discussion, we address the classification accu-
racy at the different ages. Based on the trajectories in
Figure 4, we would expect the greatest differences
between individuals in the two groups to be seen at 9 to
12 months. We surmise that these reflect quite different
developmental patterns at a time when critical
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any medium, provided the original work is properly cited.developmental milestones relevant to autism characteris-
tics are reached. After 18 months, the group averages
seem to follow similar paths. The majority of infants in
the high risk group are expected to develop in such a
way as to not be diagnosed with autism spectrum disor-
der (ASD) We note that some recent studies indicate
that about 20% of the high risk siblings will develop aut-
ism; this number seems to be borne out by our current
data, which now includes over 75 high risk infants. In
addition, we can expect, based on other studies of high
risk infants, that a further 10% or more of the children
will have other early developmental problems, such as
delayed language acquisition. Whether there are unique
features in the MSE data, and particularly in the growth
trajectories, to enable high risk infants that do develop
an ASD diagnosis to be distinguished from those who
do not, will be determined when we are able to analyze
data for all infants after they have graduated from our
study and have received a confirmed diagnosis of ASD
or no ASD.
We can say for certain that the MSE values between
the high risk and typical groups are quite different from
9 to 12 months and after that not so different. It also
appears that MSE changes in a discernible fashion dur-
ing normal early development and that our group of
high risk siblings exhibits a different MSE growth trajec-
tory. The MSE features that may differentiate infants
who eventually develop an ASD diagnosis cannot be
determined in our current study because we had no
data at all on which infants will fall into that class.
Further interpretation will have to wait until more data
are available. Until that time, statements about whether
the classification accuracy of our results at different ages
support or do not support the possibility that MSE is a
developmental indicator that can be used to detect
developing autistic tendencies cannot be evaluated.
However, the group differences found in this study are
between typically developing infants and those with a
genetic predisposition for developing autism spectrum
disorder. Although there are many confounds and com-
plexities that may eventually show that MSE trajectories
are not useful early ASD biomarkers, these results make
it reasonable to ask the question: is EEG complexity an
early biomarker for ASD? We hope that other research-
ers will join in to help answer this question, not to
prove or disprove a scientific conjecture, but because it
may be enormously helpful to millions of children and
their families.
Abbreviations
ASD: autism spectrum disorder; EEG: electroencephalography; MSE:
multiscale entropy;
Author details
1Harvard Medical School, Boston, MA, USA.
2Children’s Hospital Boston
Informatics Program at Harvard-MIT Division of Health Sciences and
Technology, Boston, MA, USA.
3Harvard Graduate School of Education,
Cambridge, MA, USA.
4Department of Developmental Medicine, Children’s
Hospital Boston, Boston, MA, USA.
5Department of Psychology, Boston
University, Boston, MA, USA.
Authors’ contributions
WJB wrote the initial draft of this response. CAN, HTF and AT reviewed and
edited the draft, contributing comments and insights from their research in
cognitive development. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 April 2011 Accepted: 20 May 2011 Published: 20 May 2011
References
1. Griffin G, Westbury C: Infant EEG activity as a biomarker for autism: A
promising approach or a false promise? BMC Med 2011, 9.
2. Bosl WJ, Tager-Flusberg H, Nelson CA: EEG Complexity as a Biomarker for
Autism Spectrum Disorder. BMC Medicine 2011, 9:18.
3. Assaf M, Jagannathan K, Calhoun VD, Miller L, Stevens MC, Sahl R,
O’Boyle JG, Schultz RT, Pearlson GD: Abnormal functional connectivity of
default mode sub=networks in autism spectrum disorder patients.
Neuroimage 2010, 53:247-256.
4. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA,
Webb SJ: Autism and abnormal development of brain connectivity. J
Neurosci 2004, 24:9228-9231.
5. Kennedy DP, Courchesne E: The intrinsic functional organization of the
brain is altered in autism. Neuroimage 2008, 39:1877-1885.
6. Noonan SK, Haist F, Müller RA: Aberrant functional connectivity in autism:
evidence from low-frequency BOLD signal fluctuations. Brain Res 2009,
1262:48-63.
7. Mantini D, Perrucci MG, Del Gratta C, Romani GL, Corbetta M:
Electrophysiological signatures of resting state networks in the human
brain. Proc Natl Acad Sci USA 2007, 104:13170-13175.
8. Micheloyannis S, Sakkalis V, Vourkas M, Stam CJ, Simos PG: Neural networks
involved in mathematical thinking: evidence from linear and non-linear
analysis of electroencephalographic activity. Neurosci Lett 2005,
373:212-217.
9. Schinkel S, Marwan N, Kurths J: Brain signal analysis based on
recurrences. J Physiol Paris 2009, 103:315-323.
10. Uhlhaas PJ, Roux F, Rodriguez E, Rotarska-Jagiela A, Singer W: Neural
synchrony and the development of cortical networks. Trends Cogn Sci
2009, 14:72-80.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1741-7015/9/60/prepub
doi:10.1186/1741-7015-9-60
Cite this article as: Bosl et al.: Response: Infant EEG activity as a
biomarker for autism: A promising approach or a false promise? BMC
Medicine 2011 9:60.
Bosl et al. BMC Medicine 2011, 9:60
http://www.biomedcentral.com/1741-7015/9/60
Page 2 of 2